FDA approves NeuroMetrix pain device

|By:, SA News Editor

The FDA grants 510(k) clearance to NeuroMetrix's (NURO) Sensus chronic pain treatment device. The wearable product delivers non-invasive electrical stimulation to sensory nerves as a method to relieve pain. It can be worn day and night and will be available over-the-counter without a prescription.

NURO shares are up 28% premarket on light volume.